XML 40 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Financial Instruments
12 Months Ended
Dec. 31, 2018
Fair Value Disclosures [Abstract]  
Financial Instruments
FINANCIAL INSTRUMENTS

The Company's only financial assets and liabilities which are measured at fair value on a recurring basis relate to certain aspects of the Company's benefit plans and our derivative instruments. We use the market approach to value certain assets and liabilities at fair value using significant other observable inputs (Level 2) with the assistance of a third party specialist. We do not have any assets or liabilities measured at fair value on a recurring basis using quoted prices in an active market (Level 1) or significant unobservable inputs (Level 3). Gains and losses related to the fair value changes in the deferred compensation assets and liabilities are recorded in General and Administrative Expenses in the Consolidated Statements of Operations. Gains and losses related to the fair value of the interest rate swaps are recorded in Other Comprehensive Income. The following table summarizes the fair value balances (in thousands):

 
Fair Value Measurement at December 31, 2018
 
Total
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
   Deferred compensation assets (1)
$
42,161

 
$

 
$
42,161

 
$

   5 year interest rate swap
135

 

 
135

 

 
$
42,296

 
$

 
$
42,296

 
$

 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
   Deferred compensation plan
$
33,287

 
$

 
$
33,287

 
$

   10 year interest rate swap
70

 

 
70

 

 
$
33,357

 
$

 
$
33,357

 
$



 
Fair Value Measurement at December 31, 2017
 
Total
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
   Deferred compensation assets (1)
$
46,145

 
$

 
$
46,145

 
$

   5 year interest rate swap
70

 

 
70

 

 
$
46,215

 
$

 
$
46,215

 
$

 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
   Deferred compensation plan
$
37,280

 
$

 
$
37,280

 
$

   10 year interest rate swap
492

 

 
492

 

 
$
37,772

 
$

 
$
37,772

 
$

(1) Deferred compensation assets consist of the cash surrender value of life insurance policies and are intended to assist in the funding of the deferred compensation arrangements.